Dr.rer.nat.,Postdoctoral researcher - investigating pharmacological modulations of host-pathogen interactions with a special focus on lipid mediators. #WerzLab
We are thrilled to invite you to the annual meeting of CRC TR124 "FungiNet – Pathogenic fungi and their human host" and "Invasive Mycoses in Haematological Malignancies – IMIHM XV".
📅 Date: March 31 - April 1, 2025
📍 Location: University of Wuerzburg, IMIB
#Mycology#Fungi
I'm so happy to share our new paper about novel potent and selective mPGES-1 inhibitors for the treatment of inflammation, pain, and fever, which we just recently published in the Journal of Medicinal Chemistry! https://t.co/h6X9kPXc5K
Time for interdisciplinary #LIFEScience CONNECTions! 🦠📷
LIFE offers funding through the "Connect" fund and more. Meet researchers and network with local companies & intitatives at the 3rd LIFE Symposium!
🗓️Nov 6, 2024
🔗https://t.co/A94IxpRG90
@UniJena@uniklinik_jena
Check out our new protocol for lipid mediator profiling in human macrophages during host-pathogen interaction, published in STAR protocols. #lipidmediators#macrophags https://t.co/1RiVt76l12
I'm happy to share our new work about the fungal toxin gliotoxin, which modulates macrophage activation and lipid mediator networks. Thanks for all the contributions within the @TRR_FungiNet consortium.
https://t.co/EZCpArSzC1
I'm excited to have this out in the world. Kudos to Rachel Grazda 🎉! We pursued the curious link between IFNg-dependent monopoiesis that accompanies bone marrow failure, and we began by asking why aren't dead cells being cleared? https://t.co/Ihc1bzKDO0
We have wonderful news, our boswellia serrata project goes on! We have a new manuscript in Frontiers Pharmacology. We found that Frankincense extracts could modulate lipid mediator biosynthesis in innate immune cells. #inflammation#resolution
https://t.co/FrzsVPVDkD
Happy to share a review @CNSerhanLab and I have been working on highlighting the importance of inflammation resolution in vascular inflammation and atherosclerotic CVD! @NatRevCardiol@AlbanyMed@AlbanyMedMCP
Yes!!! a long time ago, we started that project and finally it could be published in iScience. We investigated the impact of Influenza A virus on lipid mediator formation in human macrophages. Have a look:)
Cannabidiol acts as molecular switch in innate immune cells to promote the biosynthesis of inflammation-resolving lipid mediators by Peltner, Werz, @PMJordan92, et al at @LSU_BioSci@UninaIT@UniJena@UniAvogadro https://t.co/bD5S5mjZni
As a community we believe that in a time where misinformation has negatively affected public opinion around many important topics it is a essential that facts are presented in a balanced and unbiased manner in Scientific journals @ScienceMagazine
Yesterday, the 2nd LIFE Symposium took place. So many different and amazing presentations. Thanks a lot for funding my mast cell research with the LIFETalent fund to the amount of 4000€! @profillinie@UniJena
A big thank you to all participants, keynote speakers, talk and poster presenters, and everyone who made our #FungiNet meeting such an inspiring event! See you next time!
Online now! Cannabidiol acts as molecular switch in innate immune cells to promote the biosynthesis of inflammation-resolving lipid mediators by Peltner, Werz, @PMJordan92, et al at @LSU_BioSci@UninaIT@UniJena@UniAvogadro#chembiol https://t.co/HN8CTgFJYw
New Research: Differential impact of 5-lipoxygenase-activating protein antagonists on the biosynthesis of leukotrienes and of specialized pro-resolving mediators #pharmacology https://t.co/9oeX8b2szZ
🎉 Exciting news! Our latest open access publication in ACS Omega explores "Substituted 1,2,4-Triazoles as Novel and Selective Inhibitors of Leukotriene Biosynthesis Targeting 5‑Lipoxygenase-Activating Protein" 🧪 These compounds could be a new class of anti-inflammatory agents.